Vice President, Diabetes Care and Vision Communications
MORRISVILLE, N.C. ─ May 20, 2013 ─ TearScience®, a privately held medical device company, today announced an agreement with Vision Source, a network of private practice optometrists that share knowledge and resources to provide the best eye care, to make TearScience’s solution for identifying and treating evaporative dry eye available to its members. Vision Source members are well known for pioneering advanced technology in their eye care practices.
More than 23 million Americans suffer from dry eye disease. With the majority (86 percent) suffering from evaporative dry eye, this represents a more than $10 billion market potential in North America. TearScience® has developed and launched its solution to address this underserved patient population. The solution includes the LipiView® Ocular Surface Interferometer and the LipiFlow® Thermal Pulsation System. Evaporative dry eye occurs when Meibomian glands in the eyelids become obstructed and do not secrete the oily lipids needed to keep the water portion of tears from evaporating too quickly. LipiView® measures the absolute thickness of the lipid layer of a dry eye patient’s tear film and helps identify if a dry eye patient is a partial blinker, a condition that may limit lipid production and impact the ocular surface. LipiFlow® treats the root cause of evaporative dry eye disease by unblocking obstructed Meibomian glands during an in-office procedure.
“Meibomian Gland Dysfunction is a highly common and progressive disease,” said John McCall, OD, senior vice president of vendor relations for Vision Source. “Vision Source members recognize the importance of identifying and treating this chronic condition early. Our partnership with TearScience® will help our members stay at the forefront of managing this chronic disease.”
TearScience® exhibited at Vision Source’s annual meeting in Las Vegas from April 24-27, 2013.
“The annual meeting provided a great opportunity for TearScience® to engage Vision Source members,” said Wade Hampton, TearScience’s chief commercial officer. “The response to our technology at the meeting exceeded our expectations. Vision Source and TearScience® share the common goal of wanting to provide the best care to dry eye patients. Using our LipiView® and LipiFlow® technology, Vision Source members differentiate their practices with the ultimate goal of increasing dry eye patient satisfaction.”